Jane Street Group LLC Acquires New Holdings in iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN)

Jane Street Group LLC acquired a new stake in shares of iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRNFree Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 10,150 shares of the company’s stock, valued at approximately $254,000. Jane Street Group LLC owned approximately 6.77% of iShares Neuroscience and Healthcare ETF as of its most recent filing with the Securities & Exchange Commission.

iShares Neuroscience and Healthcare ETF Stock Down 3.3 %

NYSEARCA:IBRN opened at $24.75 on Friday. iShares Neuroscience and Healthcare ETF has a 12 month low of $22.67 and a 12 month high of $28.74. The firm has a market cap of $3.71 million, a price-to-earnings ratio of 28.31 and a beta of 1.06. The company’s 50 day moving average is $26.41 and its 200-day moving average is $25.72.

About iShares Neuroscience and Healthcare ETF

(Free Report)

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap.

Recommended Stories

Want to see what other hedge funds are holding IBRN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRNFree Report).

Receive News & Ratings for iShares Neuroscience and Healthcare ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Neuroscience and Healthcare ETF and related companies with MarketBeat.com's FREE daily email newsletter.